Patrick F. Williams

CIK 1562229 · Chief Financial Officer · last filed 2026-11-17

Patrick F. Williams is a Chief Financial Officer who has filed 40 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing shows the insider bought $99.1K of NPCE on Nov 17, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions. 17 SEC filings were submitted jointly with Zeltiq Aesthetics Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$2.06M
Companies
5
Total Filings
40
Lifetime Open-Market Net
-$3.01M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

ZLTQ price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O ZELTIQ AESTHETICS INC.
4698 WILLOW ROAD, SUITE 100
PLEASANTON, CA 94588
Related Filers
Zeltiq Aesthetics Inc — 17 joint filings, latest 2016-02-23
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NPCE Chief Financial Officer 79,399 $8.19 $649.9K $99.1K 4 2026-11-17
STAA Chief Financial Officer 56,242 $25.13 $1.41M -$1.07M 14 2025-03-14
BRTX Director — $1.31 — $0 5 2025-02-19
Sientra, Inc. (SIEN) Delisted General Manager miraDry & SVP 14,348 $0.17 $2.5K $100.0K 3 2018-08-08
Zeltiq Aesthetics Inc (ZLTQ) Delisted SVP & CFO 73,117 — — -$2.14M 14 2016-02-23

Recent Filings

40 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2026-11-17 NPCE Buy (P) +11,891 $99.1K EDGAR
2026-09-21 NPCE Tax (F) −1,162 -$16.6K EDGAR
2026-05-19 NPCE Grant (A) +16,820 $0 EDGAR
2025-06-24 NPCE Grant (A) +51,850 $0 EDGAR
2025-03-14 STAA Exer (M) +8,153 $0 EDGAR
2025-03-11 STAA Exer (M) +9,750 $0 EDGAR
2025-02-19 BRTX Grant (A) — $0 EDGAR
2024-03-14 STAA Grant (A) — $0 EDGAR
2024-03-11 STAA Exer (M) +2,614 $0 EDGAR
2024-02-15 BRTX Grant (A) — $0 EDGAR
Showing 1–10 of 40
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).